ADM’s DE111TM gut health probiotic approved in China

The approval follows research demonstrating DE111 spore-forming probiotic’s quality and safety.

ADM has announced its spore-forming probiotic DE111 (Bacillus subtilis) has been approved by the National Health Commission (NHC) in China.

With the approval from NHC, Chinese customers now have access to DE111, with knowledge that the probiotic has undergone evaluation and meets China’s quakity and safety requirements.

“ADM is committed to providing innovative functional ingredients and solutions that meet the highest regulatory standards and which meet the legislative criteria in China, and worldwide,” said Helen Hu, president of health and wellness APAC at ADM. “The approval process required by governmental authorities are rigorous and thorough, and this achievement is a significant milestone in our market development. ADM is the first and only provider of the Bacillus subtilis food ingredient to the Chinese market.”

“China is projecting substantial growth opportunities for biotics,” continued Hu. “This is in part due to the country’s drive towards innovation, in addition to its strong population, economy and history of focusing on preventative wellness solutions. With the approval of DE111, we can empower individuals across the globe to proactively manage their wellness goals with our science-backed gut health microbiome-supporting solutions,” continued Hu.

DE111 has clinically documented results showing that it supports digestive health and healthy immune function. It can also survive through the stomach and germinate in the small intestine and supplementing with DE111 can support a healthy gastrointestinal tract, gut function and microbiome diversity within the gut. As a spore-forming probiotic, DE111 retains functionality through challenging processing conditions, that may otherwise damage conventional probiotics, and is shelf stable, which makes it suitable for a wide range of different foods, beverages, and dietary supplements.

According to an FMCG Gurus study, 78% of Chinese consumers recognise the link between their digestive health and overall well-being, and 78% find food and drink products positioned around improving digestive health appealing. Further, 57% of Chinese consumers have used probiotics/cultures to address digestive health concerns over the past 12 months.

This focus on digestive health and probiotics coincides with the predicted growth of the Chinese probiotic supplement market, with a forecasted CAGR of 11.7% between 2021 and 2026. ADM expanded its health and wellness solutions library to include DE111 following the company’s acquisition of Deerland Probiotics & Enzymes in 2021. Through ADM’s global reach, the availability and approval of DE111 is now widespread.